Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Morphoceuticals Raises $8 million to Advance Electroceutical Approach to Regenerative Medicine
Morphoceuticals, a biotechnology company, announced it closed an $8 million Seed-2 funding round led by […]
Axogen Appoints Jens Schroeder Kemp as Chief Marketing Officer
Axogen, a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, […]
Ryne Biotechnology Awarded $4 Million from the California Institute for Regenerative Medicine
Ryne Biotechnology, a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and […]
Formosa Pharmaceuticals Announces Development Collaboration Agreement with Eyenovia
Taiwan-based Formosa Pharmaceuticals announced today that the company has entered into a collaboration agreement with […]
BiPER Therapeutics Raises €1.25 Million in Seed Funding to Develop First-in-class Small Molecules to Treat Gastrointestinal Cancers
BiPER Therapeutics, a preclinical biotechnology company developing first-in-class drug candidates targeting BiP protein to treat […]
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
Johnson & Johnson has announced the appointment of John Reed, to the Company’s Executive Committee as […]
Life Biosciences Appoints Sharon Rosenzweig-Lipson, PhD as Chief Scientific Officer
Life Biosciences, a pioneering life sciences company developing therapeutics that target the biology of aging, […]
Harbinger Health Appoints Vincent Lozada as Chief Financial Officer
Harbinger Health, a biotechnology company pioneering the detection of early cancer, announced today the appointment […]
U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax' COVID-19 Vaccine
Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, […]
LegoChem Biosciences Signs License Agreement to Acquire First-in-class Antibody From Elthera
LegoChem Biosciences announced on February 13, 2023 a license agreement with Elthera AG, a biotechnology […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more